16 November 2018
How Can Blockchain Disrupt the Pharma Industry?
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Trending menu:
Comment
-
14 November 2018
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the impact it has on families
-
14 November 2018
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
-
9 November 2018
Poor Communication Can Cost You – REALLY Cost You
Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an organization
-
2 November 2018
Global Standards for Identification: Untapped Opportunities in the Clinical Trial Supply Chain
Jesper Franke, Head of Healthcare, GS1 Denmark, explains how the industry can best improve supply chain processes by adopting industry standards
-
1 November 2018
Virtual Clinical Trials: Are Site-less Trials the Future?
CTA’s Anne-Marie Mongan unpacks the tangible benefits of going virtual
-
29 October 2018
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient recruitment and retention in Latin America
-
25 October 2018
Surveying the Challenges of Preclinical Development
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s upcoming Preclinical Development Operations Summit in November
-
24 October 2018
Industry Viewpoints: The Continual Rise of Direct-to-Patient
Michael Sparozic, Lead Trial Supply Operations Manager, Sanofi, address the merits of direct-to-patient shipping to CTA’s Jisong Seo
-
23 October 2018
Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on how to create efficiencies within the clinical supply chain